GH NASDAQ Week ended 31 Jul 2026

Weekly Investor Report

Guardant Health Inc · Healthcare · Diagnostics & Research

Open interactive chart View report data
Latest close 162.0 USD
10.0% latest week
Weekly setup

Mixed setup

The weekly trend is active. Price is 42.5% above the Trend Line and sits at 89.2% of its 52-week range. The latest completed week returned 10.0%, after a -3.6% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. Options positioning is mixed with 42/100 conviction, while the latest news-sentiment score is 57/100.

Setup score 64 out of 100
Latest Close 162.0 USD 31 Jul 2026
1W Return 10.0% latest completed week
4W Return -3.6% short-term follow-through
12W Return 69.3% quarterly tape
Trend Breadth 76.9% 40 of 52 weeks active
Volume Ratio 1.0x vs 13-week average
What is working
  • The trend backdrop is active with a 8-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • 8 reversal markers appear in the recent smart-money tape.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 10.0% Latest completed week; four-week move -3.6%. Indicator stack 70/66 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Options pressure Mixed 42/100 conviction; expected move 15.2%. News sentiment 57/100 55 relevant articles in the latest sentiment read. Event risk 30 Jul Latest stored earnings date was 30 Jul 2026.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 42.5% above the Trend Line and sits at 89.2% of its 52-week range. The latest completed week returned 10.0%, after a -3.6% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.0x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.8712-week average 0.53

12-week confirmation

Trend active8/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure10/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.87Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers88 reversal markers

No recent accumulation markers. 8 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -3.6% over four weeks, 69.3% over 12 weeks, and 291.1% over one year. The current trend has remained active for 8 consecutive weeks.

Performance by holding period

1W10.0%
4W-3.6%
12W69.3%
26W42.0%
52W291.1%
Active trend streak8 weeks
Active weeks in one year40
Trend breadth76.9%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.96Latest activity-pressure read.
Pressure change-20.4%Four-week change in activity pressure.
Leadership51.69Latest relative-leadership reading.
RS change-18.4%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 76% Model confidence 73%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength59/100Blend of value, momentum, and quality. Underlying universe rank 42; rank 1 is best.
Value53/100Relative valuation strength. Underlying universe rank 48; rank 1 is best.
Quality52/100Profitability and accounting quality. Underlying universe rank 49; rank 1 is best.
Momentum54/100Medium-term price momentum. Underlying universe rank 47; rank 1 is best.
Growth54/100Revenue and earnings growth. Underlying universe rank 47; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
18.1x
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-0.6%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
64.9%
Gross profit retained from each unit of revenue.
Operating margin
-39.8%
Operating profit retained from revenue.
Free-cash-flow margin
-11.7%
Free cash flow generated from revenue.
Return on invested capital
-60.4%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
39.6%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
5/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
-1.8%
Net share repurchases relative to market value.
Shareholder yield
-1.8%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-1.8x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningMixed

GH shows mixed options pressure with a 42/100 conviction score, put-call volume ratio of 0.94, expected move of 15.2%, and Sharemaestro trend signal active.

Conviction42/100
Expected move15.2%
Put/call volume0.94
Pressure1
Speculation41
Volatility81
Trend agreement92
Open options detail
Insider activity3 / 17

3 acquisitions and 17 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment57/100

Weighted news tone is neutral across 55 relevant articles.

21 positive · 32 neutral · 2 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings30 JulLatest stored earnings date was 30 Jul 2026.
Options expected move15.2%Nearest-chain priced movement where available.
52-week drawdown-8.3%Distance below the 52-week high.
13-week volatility8.7%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher11 of 2615 weeks finished lower.
Best week+25.3%Week of 22 May.
Worst week-16.2%Week of 10 Apr.
Latest week+10.0%Week of 31 Jul.

Shape of recent returns

Strong gains9
Modest gains2
Flat weeks0
Modest losses9
Sharp losses6
Recent vol8.7%13-week weekly-return volatility.
Base vol9.2%52-week weekly-return volatility.
Up/down split30/22Count of positive and negative weeks in the 52-week window.
Average skew8.6% / -4.5%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape60/100

Trend, activity pressure, participation, and risk combine to a 60/100 tape read.

 Indicator analysis69/100

Latest 12-week confirmation: trend 8/12, activity pressure 10/12, relative leadership 12/12.

Activity pressure 0.87; 8 reversal markers Factors54/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 78; Small Cap Core rank 52 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options60/100

GH shows mixed options pressure with a 42/100 conviction score, put-call volume ratio of 0.94, expected move of 15.2%, and Sharemaestro trend signal active.

Mixed · Options-market disagreement · Expected move 15.2% Sentiment57/100

Weighted news tone is neutral across 55 relevant articles.

Guardant Health (GH) Stock Jumps As Shield Growth Masks Loss Pressure Insiders3 / 17

3 acquisitions and 17 disposals in the latest 180-day insider tape.

 Earnings30 Jul

Latest stored earnings date was 30 Jul 2026.

 Research flow5 items

2 recent research articles and 3 Market Watch posts are available.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 2026162.0 USD10.0%113.7 USD54.14 USD0.9651.6912.9MOn
24 Jul 2026147.3 USD-5.5%111.7 USD53.35 USD1.0741.538.1MOn
17 Jul 2026155.9 USD-2.6%110.2 USD52.65 USD1.3149.939.5MOn
10 Jul 2026160.1 USD-4.7%108.4 USD51.89 USD1.2950.2813.8MOn
3 Jul 2026168.0 USD12.6%106.4 USD51.11 USD1.2163.3516.3MOn
26 Jun 2026149.2 USD13.2%104.2 USD50.28 USD1.1249.2328.6MOn
19 Jun 2026131.8 USD0.1%102.9 USD49.55 USD1.0427.919.8MOn
12 Jun 2026131.6 USD4.8%102.0 USD48.93 USD1.1132.729.3MOn
5 Jun 2026125.6 USD-3.1%100.7 USD48.33 USD0.8331.2112.0MOff
29 May 2026129.7 USD9.0%99.78 USD47.73 USD0.4530.9911.9MOff
22 May 2026119.0 USD25.3%98.56 USD47.11 USD-0.0825.3615.0MOff
15 May 202694.92 USD-0.8%97.00 USD46.52 USD-0.602.619.3MOff
8 May 202695.70 USD9.2%96.01 USD46.11 USD-0.713.9710.1MOff
1 May 202687.60 USD-1.5%94.96 USD45.66 USD-0.841.1410.6MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.